Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Gibco™ KnockOut™ Serum Replacement
GREENER_CHOICE

KnockOut™ Serum Replacement

Supplier:  Gibco™ 10828028

Encompass_Preferred

 View more versions of this product

Catalog No. 10-828-028


Due to product restrictions, please to purchase or view availability for this product.

Explore available promotions
This item is not returnable. View return policy

Description

Description

Gibco™ KnockOut™ Serum Replacement (KnockOut™ SR) is a more defined, FBS-free medium supplement that supports the growth of pluripotent stem cells (PSCs) cultured on fibroblast feeder cells. Designed to replace fetal bovine serum (FBS) in existing protocols, this serum replacement has been trusted by many for almost 20 years. Providing the documents required for regulatory review, KnockOut SR reduces your burden in qualifying reagents when transitioning from research applications to clinical applications. If you are interested in only basic research applications, see the Research Use Only version of this product to ensure that you receive the benefits and pricing that fit your needs.

With KnockOut Serum Replacement, you can:
  • Culture feeder-dependent PSCs with confidence
  • Rely on the improved performance of a qualified, FBS-free formulation
  • Enjoy the peace of mind of having a more stable price and supply compared to FBS

    Culture PSCs with confidence
    KnockOut SR has been cited in more than 2000 publications. It has been shown to support feeder-dependent culture of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). It has also been shown to support reprogramming, embryoid body (EB) formation, in vitro differentiation, cryopreservation, ESC derivation, and many other applications.

    Rely on improved performance
    KnockOut SR has more a defined formulation compared to FBS, which contains many undefined and variable components. Unlike most FBS products, each lot is tested for its ability to support PSCs. Because of this, culturing PSCs with KnockOut SR leads to less differentiation and more compact colony morphology compared to FBS.

    Enjoy the peace of mind of having stable price and supply
    KnockOut SR is not affected by the limited supply and fluctuating prices often seen with FBS. This makes it easier to plan your budget and buy what you need, especially since it is more affordable than most FBS products.



    This reagent is classified as a medical device in several countries. If it is not regulated as a medical device in a specific region, it should be used for laboratory use only.
    TRUSTED_SUSTAINABILITY
  • Specifications

    Specifications

    Serum-Free
    Stem Cell (Embryonic, iPS - Induced Pluripotent Stem)
    Frozen
    Serum Replacement
    cGMP for medical devices, 21 CFR Part 820 and ISO 13485
    Sustainable packaging
    6 to 8
    Store in freezer (-5 to -20°C) and protect from light.
    Stem Cells (Embryonic),Stem Cells (iPS - Induced Pluripotent Stem)
    Serum-Free
    500 mL
    Clinical Research, Translational Research
    KnockOut™
    Dry Ice
    Safety and Handling

    Safety and Handling

    ShelfLife : 18 Months

    WARNING: Cancer - www.P65Warnings.ca.gov
    SDS
    Documents

    Documents

    Product Certifications
    Promotions

    Promotions

    Product Content Correction

    The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

    Product Title

    By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.